{"nctId":"NCT02536781","briefTitle":"Efficacy of Anthocyanin Mouthrinse for Oral Anti-inflammation From Orthodontic Treatment","startDateStruct":{"date":"2015-08"},"conditions":["Inflammation of Mouth","Acute Mucous Inflammation"],"count":70,"armGroups":[{"label":"Placebol","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"Anthocynin","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Anthocyanin"]}],"interventions":[{"name":"Anthocyanin","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male and/or females between the ages of 18 and 35 with oral inflammation, investigated by a dentist, caused by orthodontic devices.\n* The inflammatory lesions are occurred at labial and/or buccal mucosa.\n* Be able to communicate well with the investigator and to comply with the requirements of the entire study.\n* Not participate in other project(s).\n* Be willingness to give written informed consent (prior to any study-related procedures being performed) and to be able to adhere to the study restrictions and examination schedule.\n\nExclusion Criteria:\n\n* \\- Have the persistent inflammatory lesions and/or ulcers that cannot be healed more than 2 weeks or the inflammation that may lead to be oral cancer.\n* Have severe oral inflammation or the inflammation occur from ongoing head and neck chemotherapy or serious oral inflammatory such as periodontitis and oral lichen planus.\n* Taking steroid or applying topical steroid within or 7 days before participated in this study.\n* Have a history of allergy or hypersensitivity to any red, blue, or purple color fruits and vegetables such as berry groups.\n* Patients with auto-immune diseases or diseases that related to wound healing process such as diabetes.\n* Patients that cannot meet the follow up or drop out of the experiments.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"25 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Wound Size (mm^2) Reduction","description":"Comparing between the active and placebo about the wound size reduction from day 0 to day 7 after treatment","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11.26","spread":"14.22"},{"groupId":"OG001","value":"8.92","spread":"14.86"}]}]}]},{"type":"SECONDARY","title":"VAS Scores Range From 0 (no Pain) to 10 (Severe Pain)","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.53","spread":"1.67"},{"groupId":"OG001","value":"0.96","spread":"0.68"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":36},"commonTop":[]}}}